Pages 601 - 605
SPICE various synthetic cannabinoid mixtures - also see the HU and JWH and CP series
Withdrawal Phenomena and Dependence Syndrome After the Consumption of "Spice
Gold" (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719097/?tool=pmcentrez Spice: a never ending story? (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19589652
Pharmacological properties and dependence liabilities of synthetic cannabinoids
(abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20681249/abstract/[Pharmacological_propertie s_and_dependence_liabilities_of_synthetic_cannabinoids%5D_
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20117892
Spice drugs as a new trend: mode of action, identification and legislation. (abst – 2010)
http://www.ncbi.nlm.nih.gov/pubmed/20566335
Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20857386
Inhaled Incense "K2" May Cause Heart Damage (news – 2010)
http://drwes.blogspot.com/2010/08/inhaled-incense-k2-may-cause-heart.html
Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse? (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139381/?tool=pubmed
Beyond THC: The New Generation of Cannabinoid Designer Drugs. (full – 2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187647/?tool=pubmed
Investigating a not-so-natural high. (full – 2011)
http://pubs.acs.org/doi/full/10.1021/ac900564u
Convulsions Associated with the Use of a Synthetic Cannabinoid Product. (full – 2011)
http://www.springerlink.com/content/9651q2672027n38g/fulltext.html
Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. (full – 2011)
http://docstore.ingenta.com/cgi- bin/ds_deliver/1/u/d/ISIS/66605491.1/pres/jat/2011/00000035/00000007/art00013/33697C59B13F9CFB13 26169859E74280D392B0112D.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf
Psychosis Associated With Synthetic Cannabinoid Agonists: A Case Series (letter – 2011) http://ajp.psychiatryonline.org/cgi/content/full/168/10/1119
The "new" marijuana. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21325097
601
The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21482092
Severe toxicity following synthetic cannabinoid ingestion. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21970775
The emergence and analysis of synthetic cannabinoids. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21337724
Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20529459
"Spice" girls: synthetic cannabinoid intoxication. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21167669
Three cases of "spice" exposure. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21740143
"Legal highs" - new players in the old drama. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21711229
Comparison of "herbal highs" composition. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21318244
Synthetic cannabinoid use: a case series of adolescents. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21939863
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22065271
Cytotoxicity of synthetic cannabinoids found in "Spice" products: the role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21907772/abstract/Cytotoxicity_of_synthetic_cann abinoids_found_in_%22Spice%22_products:_the_role_of_cannabinoid_receptors_and_the_caspase_cascad e_in_the_NG_108_15_cell_line_
High-performance sport, marijuana, and cannabimimetics. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/22080902
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats.
(abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21640532/abstract/Effects_of_synthetic_cannabino ids_on_electroencephalogram_power_spectra_in_rats_
Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?
(abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21441120/abstract/Marijuana_based_drugs:_innov ative_therapeutics_or_designer_drugs_of_abuse
602
Detection of synthetic cannabinoids in herbal incense products. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21741374
'Fake Marijuana' May Trigger Heart Trouble in Teens (news – 2011)
http://health.yahoo.net/news/s/hsn/fakemarijuanamaytriggerhearttroubleinteens
Chemicals Used in "Spice" and "K2" Type Products Now Under Federal Control and Regulation (news – 2011) http://www.justice.gov/dea/pubs/pressrel/pr030111.html
A survey study to characterize use of Spice products (synthetic cannabinoids). (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21835562
'Hammer Head' 'incense' blamed for seizure of youth in Le Roy (news – 2012)
http://thebatavian.com/howard-owens/hammer-head-incense-blamed-seizure-youth-le-roy/29983
SPINAL CORD INJURY
The perceived effects of marijuana on spinal cord injured males.
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=138
Marihuana as a therapeutic agent for muscle spasm or spasticity.
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=53
Cannabis effect on spasticity in spinal cord injury. (abst - 1982)
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=113
The effect of delta-9-THC on human spasticity. (abst - 1986)
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=154
(abst - 1974) (abst - 1980)
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. (abst - 1990) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=160
Treatment of spasticity in spinal cord injury with dronabinol, a tetrahydrocannabinol derivative. (abst - 1995) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=112
The effect of orally and rectally administered delta-9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. (abst - 1996) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=12
Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord (full - 1997) http://jpet.aspetjournals.org/content/281/2/730.full
Cannabis and cannabinoids: pharmacology and rationale for clinical use (abst – 1999)
http://pharmgkb.org/pmid/10575283
603
Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. (full – 2001) http://jn.physiology.org/content/86/6/3061.long
Clinical investigation of delta-9-tetrahydrocannabinol (THC) as an alternative therapy for overactive bladders in spinal cord injury (SCI) patients. (abst - 2001) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=102
The treatment of spasticity with D9-tetrahydrocannabinol (D9-THC) in patients with spinal cord injury (abst - 2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=79
Therapeutic potential of cannabinoids in CNS disease. (abst - 2003)
http://www.ncbi.nlm.nih.gov/pubmed/12617697
Antinociceptive effect of cannabinoid agonist WIN 55,212–2 in rats with a spinal cord injury (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1861843/?tool=pmcentrez
Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain (full - 2006) http://jn.physiology.org/cgi/content/full/96/6/2984
The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury. (abst - 2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=166
Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. (full – 2008) http://jpet.aspetjournals.org/content/326/1/12.long
Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743245/?tool=pmcentrez
The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function (full – 2009) http://content.karger.com/produktedb/produkte.asp?DOI=000201556&typ=pdf
Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826109/?tool=pubmed
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study. (abst – 2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=313
(abst - 2004) Treatments for Chronic Pain in Persons With Spinal Cord Injury: A Survey Study
Are oral cannabinoids safe and effective in refractory neuropathic pain?
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=143
(full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1864800/?tool=pmcentrez
604
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20156559
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20434606
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172222/?tool=pubmed
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury
(abst – 2011) http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/lb422?maxtoshow=&hits=80& RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype =HWCIT
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions.
(abst – 2011)
http://www.unboundmedicine.com/medline/ebm/record/21265596/abstract/Spinal_Cord_Injuries_Induce_ Changes_of_CB1_Cannabinoid_Receptor_and_C_C_Chemokine_Expression_in_Brain_Areas_Underlying _Circuitry_of_Chronic_Pain_Conditions_
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21970496
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21813113
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21915768
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507
605
SPICE various synthetic cannabinoid mixtures - also see the HU and JWH and CP series
Withdrawal Phenomena and Dependence Syndrome After the Consumption of "Spice
Gold" (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719097/?tool=pmcentrez Spice: a never ending story? (abst – 2009) http://www.ncbi.nlm.nih.gov/pubmed/19589652
Pharmacological properties and dependence liabilities of synthetic cannabinoids
(abst – 2010) http://www.unboundmedicine.com/medline/ebm/record/20681249/abstract/[Pharmacological_propertie s_and_dependence_liabilities_of_synthetic_cannabinoids%5D_
Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20117892
Spice drugs as a new trend: mode of action, identification and legislation. (abst – 2010)
http://www.ncbi.nlm.nih.gov/pubmed/20566335
Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20857386
Inhaled Incense "K2" May Cause Heart Damage (news – 2010)
http://drwes.blogspot.com/2010/08/inhaled-incense-k2-may-cause-heart.html
Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse? (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139381/?tool=pubmed
Beyond THC: The New Generation of Cannabinoid Designer Drugs. (full – 2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3187647/?tool=pubmed
Investigating a not-so-natural high. (full – 2011)
http://pubs.acs.org/doi/full/10.1021/ac900564u
Convulsions Associated with the Use of a Synthetic Cannabinoid Product. (full – 2011)
http://www.springerlink.com/content/9651q2672027n38g/fulltext.html
Liquid chromatography-tandem mass spectrometry analysis of urine specimens for K2 (JWH-018) metabolites. (full – 2011)
http://docstore.ingenta.com/cgi- bin/ds_deliver/1/u/d/ISIS/66605491.1/pres/jat/2011/00000035/00000007/art00013/33697C59B13F9CFB13 26169859E74280D392B0112D.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf
Psychosis Associated With Synthetic Cannabinoid Agonists: A Case Series (letter – 2011) http://ajp.psychiatryonline.org/cgi/content/full/168/10/1119
The "new" marijuana. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21325097
601
The impact of changes in UK classification of the synthetic cannabinoid receptor agonists in 'Spice'. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21482092
Severe toxicity following synthetic cannabinoid ingestion. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21970775
The emergence and analysis of synthetic cannabinoids. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21337724
Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20529459
"Spice" girls: synthetic cannabinoid intoxication. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21167669
Three cases of "spice" exposure. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21740143
"Legal highs" - new players in the old drama. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21711229
Comparison of "herbal highs" composition. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21318244
Synthetic cannabinoid use: a case series of adolescents. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21939863
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22065271
Cytotoxicity of synthetic cannabinoids found in "Spice" products: the role of cannabinoid receptors and the caspase cascade in the NG 108-15 cell line. (abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21907772/abstract/Cytotoxicity_of_synthetic_cann abinoids_found_in_%22Spice%22_products:_the_role_of_cannabinoid_receptors_and_the_caspase_cascad e_in_the_NG_108_15_cell_line_
High-performance sport, marijuana, and cannabimimetics. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/22080902
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats.
(abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21640532/abstract/Effects_of_synthetic_cannabino ids_on_electroencephalogram_power_spectra_in_rats_
Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?
(abst – 2011) http://www.unboundmedicine.com/medline/ebm/record/21441120/abstract/Marijuana_based_drugs:_innov ative_therapeutics_or_designer_drugs_of_abuse
602
Detection of synthetic cannabinoids in herbal incense products. (abst – 2011)
http://www.ncbi.nlm.nih.gov/pubmed/21741374
'Fake Marijuana' May Trigger Heart Trouble in Teens (news – 2011)
http://health.yahoo.net/news/s/hsn/fakemarijuanamaytriggerhearttroubleinteens
Chemicals Used in "Spice" and "K2" Type Products Now Under Federal Control and Regulation (news – 2011) http://www.justice.gov/dea/pubs/pressrel/pr030111.html
A survey study to characterize use of Spice products (synthetic cannabinoids). (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21835562
'Hammer Head' 'incense' blamed for seizure of youth in Le Roy (news – 2012)
http://thebatavian.com/howard-owens/hammer-head-incense-blamed-seizure-youth-le-roy/29983
SPINAL CORD INJURY
The perceived effects of marijuana on spinal cord injured males.
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=138
Marihuana as a therapeutic agent for muscle spasm or spasticity.
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=53
Cannabis effect on spasticity in spinal cord injury. (abst - 1982)
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=113
The effect of delta-9-THC on human spasticity. (abst - 1986)
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=154
(abst - 1974) (abst - 1980)
Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial. (abst - 1990) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=160
Treatment of spasticity in spinal cord injury with dronabinol, a tetrahydrocannabinol derivative. (abst - 1995) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=112
The effect of orally and rectally administered delta-9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients. (abst - 1996) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=12
Involvement of Dynorphin B in the Antinociceptive Effects of the Cannabinoid CP55,940 in the Spinal Cord (full - 1997) http://jpet.aspetjournals.org/content/281/2/730.full
Cannabis and cannabinoids: pharmacology and rationale for clinical use (abst – 1999)
http://pharmgkb.org/pmid/10575283
603
Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo. (full – 2001) http://jn.physiology.org/content/86/6/3061.long
Clinical investigation of delta-9-tetrahydrocannabinol (THC) as an alternative therapy for overactive bladders in spinal cord injury (SCI) patients. (abst - 2001) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=102
The treatment of spasticity with D9-tetrahydrocannabinol (D9-THC) in patients with spinal cord injury (abst - 2003) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=79
Therapeutic potential of cannabinoids in CNS disease. (abst - 2003)
http://www.ncbi.nlm.nih.gov/pubmed/12617697
Antinociceptive effect of cannabinoid agonist WIN 55,212–2 in rats with a spinal cord injury (full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1861843/?tool=pmcentrez
Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain (full - 2006) http://jn.physiology.org/cgi/content/full/96/6/2984
The treatment of spasticity with Delta(9)-tetrahydrocannabinol in persons with spinal cord injury. (abst - 2006) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=166
Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury. (full – 2008) http://jpet.aspetjournals.org/content/326/1/12.long
Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain (full - 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743245/?tool=pmcentrez
The nonpsychotropic cannabinoid cannabidiol modulates and directly activates alpha-1 and alpha-1-Beta glycine receptor function (full – 2009) http://content.karger.com/produktedb/produkte.asp?DOI=000201556&typ=pdf
Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826109/?tool=pubmed
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study. (abst – 2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=313
(abst - 2004) Treatments for Chronic Pain in Persons With Spinal Cord Injury: A Survey Study
Are oral cannabinoids safe and effective in refractory neuropathic pain?
http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=143
(full - 2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1864800/?tool=pmcentrez
604
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain. (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20156559
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. (abst - 2010) http://www.ncbi.nlm.nih.gov/pubmed/20434606
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172222/?tool=pubmed
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury
(abst – 2011) http://www.fasebj.org/cgi/content/meeting_abstract/25/1_MeetingAbstracts/lb422?maxtoshow=&hits=80& RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype =HWCIT
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions.
(abst – 2011)
http://www.unboundmedicine.com/medline/ebm/record/21265596/abstract/Spinal_Cord_Injuries_Induce_ Changes_of_CB1_Cannabinoid_Receptor_and_C_C_Chemokine_Expression_in_Brain_Areas_Underlying _Circuitry_of_Chronic_Pain_Conditions_
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21970496
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21813113
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21915768
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507
605